Decatur Capital Management, Inc. Ionis Pharmaceuticals Inc Transaction History

Decatur Capital Management, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Jan 21, 2020	SELL	$53.85 - $65.27 $3.46 Million - $4.19 Million	-64,176 Closed	0 $0
Q3 2019 Oct 11, 2019	SELL	$59.06 - $72.15 $1.47 Million - $1.79 Million	-24,875 Reduced 27.93%	64,176 $3.85 Million
Q2 2019 Jul 24, 2019	SELL	$62.09 - $86.14 $124,180 - $172,280	-2,000 Reduced 2.2%	89,051 $5.72 Million
Q1 2019 Apr 23, 2019	BUY	$52.92 - $81.17 $4.82 Million - $7.39 Million	91,051 New	91,051 $7.39 Million

415

138M

859K

617K

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $4.48B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

Get notified when there are updates to the investment portfolio of Decatur Capital Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Decatur Capital Management, Inc. with notifications on news.